Loscher et al., "Which Animal Models Should Be Used in the Search for New Antiepileptic Drugs? A Proposal Based on Experimental and Clinical Considerations," Epilepsy Research, 2, 145-181 (1988). |
Lothman et al., "Screening and Characterization of Antiepileptic Drugs with Rapidly Recurring Hippocampal Seizures in Rats," Epilepsy Research, 2, 367-379 (1988). |
White, "Clinical Significance of Animial Seizure Models and Mechanism of Action Studies of Potential Antiepileptic Drugs," Epilepsia, 38(Suppl. 1), S9-S17 (1997). |
Zurn et al., "Symptomatic Cell Therapies: Cells as Biological Minipumps," European Neurology, 36, 405-408 (1996). |
Thomas et al. (eds.), Taber's Cyclopedic Medical Dictionary, 17th Edition/Illustrated, F. A. Davis Co., Philadelphia, PA, 1993, only pp. 660-662 supplied, see especially definition of epilepsy at p. 660, column 2. |
Berkow et al. (eds.), a portion of Chapter 121 ("Seizure Disorders") in The Merck Manual of Diagnosis and Therapy, 16th Edition, Merck & Co. Rahway, NJ, 1992, only pp. 1436-1444 supplied. |
Gomaa, "Characteristics of Analgesia Induced by Adenosine Triphosphate," Pharmacology & Toxicology, 61, 199-202 (1987). |
Adami et al., 1995, Effects of repeated administration of selective adenosine A.sub.1 and A.sub.2A receptor agonists on pentylenetetrazole-induced convulsions in the rat, Eur. J. Pharmacol. 294:383-389. |
Aebischer et al., 1994, Transplantation in Humans of Encapsulated Xenogeneic Cells Without Immunosupression, Transplant 58:1275-1277 (Dec. 1994). |
Aebischer et al., 1991, Long-Term Cross-Species Brain Transplantation of a Polymer-Encapsulated Dopamine-Secreting Cell Line, Exp. Neurol. 111, 269-275. |
Aebishcer et al., 1994, Functional Recovery in Hemiparkinsonian Primates Transplanted with Polymer-Encapsulated PC12 Cells, Exp. Neurol. 126:151-158. |
Barone et al., 1989, Adenosine Receptor Prodrugs: Towards Kidney-Selective Dialkylxanthines, J. Pharmacol. Exp. Ther. 250:79-85 (Issue No. 1). |
Chin, 1989, Adenosine Receptors in Brain: Neuromodulation and Role in Epilepsy, Ann. Neurol. 26:695-698 (Issue No. 6, Dec. 1989). |
Collis and Hourani, 1993, Adenosine receptor subtypes, TIPS 14, 360-366 (Oct. 1993). |
Concas et al., 1996, Differential Antagonism by the Selective A.sub.1 Adenosine Receptor Agonist CCPA of Seizures Induced by NMDA, Kainic Acid, and Domoic Acid, Neuroscience Research Communications 18:9-18 (Issue No. 1). |
Corradetti et al., 1984, Adenosine Decreases Aspartate and Glutamate Release from Rat Hippocampal Slices, Eur. J. Pharmacol. 104:19-26. |
Cottam et al., 1993, New Adenosine Kinase Inhibitors with Oral Antiinflammatory Activity: Synthesis and Biological Evaluation, J. Med. Chem. 36, 3424-3430 (Issue No. 22). |
De Sarro et al., 1991, Anticonvulsant action of 2-chloroadenosine infected focally into the inferior colliculus and substantia nigra, European Journal of Pharmacology 194:145-152. |
Dragunow, 1988, Purinergic Mechanisms in Epilepsy, Progr. Neurobiol. 31:85-108. |
Dunwiddie and Worth, 1982, Sedative and Anticonvulsant Effects of Adenosine Analogs in Mouse and Rat.sup.1, J. Pharmacol. Exp. Therap. 220:70-76. |
Fisher et al., 1991, Survival and Function of Intrastriatally Grafted Primary Fibroblasts Genetically Modified to Produce L-Dopa, Neuron 6:371-380 (Mar. 1991). |
Fisher and Gage, 1994, Intracerebral transplantation: basic and clinical applications to the neostriatum, FASEB J. 8:489-496 (May 1994). |
Foster et al., 1994, Regulation of Endogenous Adenosine Levels in the CNS: Potential for Therapy in Stroke, Epilepsy and Pain, Adv. Exp. Med. Biol. 370:427-430. |
Franklin et al., 1988, Adenosine receptor activation blocks seizures induced by bicuculline methiodide in the rat prepiriform cortex, European Journal of Pharmacology 150:207-209. |
Fredholm 1995, Adenosine Receptors in the Central Nervous System, NIPS 10:122-128, (Jun. 1995). |
Gossen and Bujard, 1992, Tight control of gene expression in mammalian cells by tetracycline-responsive promoters, Proc. Natl. Acad. Sci. USA 89:5547-5551 (Jun. 1992). |
Gossen et al., 1995, Transcriptional Activation by Tetracyclines in Mammalian Cells, Science 268:1766-1769 (Jun. 23, 1995). |
Greene and Haas, 1991, The Electrophysiology of Adenosine in the Mammalian Central Nervous System, Progr. Neurobiol. 36:;329-341. |
Guieu et al., 1996, Adenosine and the Nervous System: Clinical Implications, Clinical Neuropharmacology 19:459-474 (Issue No. 6). |
Herberg et al., 1993, Effect of an Adenosine A.sup.1 Agonist Injected Into Substantia Nigra on Kindling of Epileptic Seizures and Convulsion Duration, Pharmacol. Biochem. Behav. 44:113-117. |
Jiao et al., 1993, Long-term correction of rat model of Parkinson's disease by gene therapy, Nature 362:450-453 (Apr. 1, 1993). |
Maillard et al., 1994, Adenosine Receptor Prodrugs: Synthesis and Biological Activity of Derivatives of Potent, A.sub.1 -Selective Agonists, J. Pharm. Sci. 83:46-53 (Issue #1, Jan. 1994). |
Maitre et al., 1974, Protective Effect of Adenosine and Nicotinamide Against Audiogenic Seizure, Biochemical Pharmacology 23:2807-2816. |
McNally et al., 1997, Cloning and Expression of the Adenosine Kinase Gene from Rat and Human Tissue, Biochem. Biophys. Res. Comm. 231:645-650 (Issue No. 3). |
Nellen and Lichtenstein, 1993, What makes an mRNA anti-sense-itive, TIBS 18:419-423 (Nov. 1993). |
Palmer and Stiles, 1995, Review: Neurotransmitter Receptors VII:Adenosine Receptors, Neuropharmacology 34:683-94 (Issue No. 7). |
Petersen, 1991, Selective protection by adenosine receptor agonists against DMCM-induced seizures, European Journal of Pharmacology 195:261-265. |
Pospisil et al., 1993, Noradrenaline Reduces Cardiovascular Effects of the Combined Dipyridamole and AMP Administration but Preserves Radioprotective Effects of these Drugs on Hematopoiesis in Mice, Physiol. Res. 42:333-340. |
Sabate et al., 1995, Transplantation to the rat brain of human neural progenitors that were genetically modified using adenoviruses, Nature Genetics 9:256-260 (Mar. 1995). |
Sagen et al., (Jun.) 1993, Transplants of Immunologically Isolated Xenogeneic Chromaffin Cells Provide a Long-Term Source of Pain-reducing Neuroactive Substances, J. Neurosci. 13:2415-2423 (No. 6). |
Sagot et al., 1995, Polymer Encapsulated Cell Lines Genetically Engineered to Release Ciliary Neurotrophic Factor Can Slow Down Progressive Motor Neuronopathy in the Mouse, Eur. J. Neurosci. 7:1313-1322. |
Sawynok and Sweeney, 1989, The Role of Purines in Nocicption, Neuroscience 32:557-569(No. 3). |
Singh et al., 1996, Cloning and characterzation of cDNA for adenosine kinase from mammalian (Chinese hamster, mouse, human and rat) species; High frequency mutants of Chinese hamster ovary cells involve structural alterations in the gene, Eur. J. Biochem. 241:564-571. |
Spychala et al., 1996, Cloning of human adenosine kinase cDNA: Sequence similarity to microbial ribokinases and fructokinases, Proc. Nat. Acad. Sci. USA 93:1232-1237 (Feb. 1996). |
Suhr and Gage, 1993, Gene Therapy for Neurologic Disease, Arch. Neurol. 50:1252-1258 (Nov. 1993). |
Tai and Sun, 1993, Microencapsulation of recombinant cells: a new delivery system for gene therapy, FASEB J. 7:1061-1069 (Aug. 1993). |
Thompson et al., 1993, Presynaptic inhibition in the hippocampus, TINS 16:222-227 (Issue No. 6). |
Ulrich and Huguenard, 1995, Purinergic Inhibition of GABA and Glutamate Release in the Thalamus: Implications for Thalamic Network Activity, Neuron 15:909-918 (Oct. 1995). |
Valerio et al., 1985, Adenosine deaminase: characterization and expression of a gene with a remarkable promoter, EMBO J. 4:437-433 (Issue No. 2). |
Voits and Frey, 1994, Stimulation-Dependent Effect of Antiepileptic Drugs in Amygdala Kindled Rats on Both Seizure Score and Duration of Afterdischarges, Pharmacol. Toxicol. 75:54-61. |
Von Lubitz et al., 1994, Chronic adenosine A.sub.1 receptor agonist and antagonist: effect on receptor density and N-methyl-D-aspartate induced seizures in mice, Eur. J. Pharmacol. 253:95-99. |
Winn et al., 1994, Polymer-encapsulated cells genetically modified to secrete human nerve growth factor promote the survival of axotomized septal cholinergic neurons, Proc. Natl. Acad. Sci. USA 91:2324-2328 (Mar. 1994). |
Winn et al., 1989, An Encapsulated Dopamine-Releasing Polymer Alleviates Experimental Parkinsonism in Rats, Exp. Neurol. 105:244-250. |
Wu and Saggau, 1994, Adenosine Inhibits Evoked Synaptic Transmission Primarily by Reducing Presynaptic Calcium Influx in Area CA1 of Hippocampus, Neuron 12:1139-1148 (May 1994). |
Zhang et al., 1994, Activation of adenosine A.sub.1 receptors underlies anticonvulsant effect of CGS21680, European Journal of Pharmacology 255:239-243. |